» Authors » Stephen L Brown

Stephen L Brown

Explore the profile of Stephen L Brown including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 164
Citations 2535
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Thoidingjam S, Sriramulu S, Hassan O, Brown S, Siddiqui F, Movsas B, et al.
bioRxiv . 2024 May; PMID: 38712071
Background: Lung cancer is a major public health concern, with high incidence and mortality. Despite advances in targeted therapy and immunotherapy, microtubule stabilizers (paclitaxel, docetaxel), DNA intercalating platinum drugs (cisplatin)...
12.
Brown S, Hope-Stone L, van der Voort N, Hussain R, Heimann H, Coventry W, et al.
Br J Health Psychol . 2024 Mar; 29(3):662-675. PMID: 38462481
Objective: Fear of cancer recurrence (FCR) may develop into elevated anxiety or depression symptoms, but few risk factors for this development are known. Objective recurrence risk estimation is possible in...
13.
Waite A, Johnston B, Boyle A, Cherry M, Fisher P, Brown S, et al.
BMJ Open . 2023 Sep; 13(9):e071730. PMID: 37758678
Introduction: Psychological distress is common in intensive care unit (ICU) survivors and is anticipated in those who were treated for severe COVID-19 infection. This trainee-led, multicentre, observational, longitudinal study aims...
14.
Brown S, Hope-Stone L, Hussain R, Heimann H, van der Voort N, Cherry M
Eye (Lond) . 2023 Sep; 38(4):707-713. PMID: 37752341
Background: Phantom eye symptoms (PES), particularly phantom visual sensations (PVS) and phantom eye pain (PEP), are common in enucleated patients and can lead to psychological distress. Current cross-sectional studies cannot...
15.
Nyati S, Stricker H, Barton K, Li P, Elshaikh M, Ali H, et al.
PLoS One . 2023 Sep; 18(9):e0291315. PMID: 37713401
In a phase I dose escalation and safety study (NCT02555397), a replication-competent oncolytic adenovirus expressing yCD, TK and hIL-12 (Ad5-yCD/mutTKSR39rep-hIL-12) was administered in 15 subjects with localized recurrent prostate cancer...
16.
Simone 2nd C, Serebrenik A, Gore E, Mohindra P, Brown S, Wang D, et al.
Int J Radiat Oncol Biol Phys . 2023 Aug; 118(2):404-414. PMID: 37652301
Purpose: Radiation therapy is part of the standard treatment regimen for non-small cell lung cancer (NSCLC). Although radiation therapy is an effective tool to manage NSCLC, it can be associated...
17.
Bagher-Ebadian H, Brown S, Ghassemi M, Nagaraja T, Movsas B, Ewing J, et al.
Sci Rep . 2023 Jul; 13(1):10693. PMID: 37394559
Here, we investigate radiomics-based characterization of tumor vascular and microenvironmental properties in an orthotopic rat brain tumor model measured using dynamic-contrast-enhanced (DCE) MRI. Thirty-two immune compromised-RNU rats implanted with human...
18.
Kaytor M, Serebrenik A, Lapanowski K, McFall D, Jones M, Movsas B, et al.
Transl Lung Cancer Res . 2023 Jun; 12(5):999-1010. PMID: 37323169
Background: Radiotherapy for non-small cell lung cancer (NSCLC) can be dose-limiting due to treatment-related toxicities. Genistein has been shown to be a robust radioprotective agent in preclinical models. A novel...
19.
Bagher-Ebadian H, Brown S, Ghassemi M, Nagaraja T, Valadie O, Acharya P, et al.
Sci Rep . 2023 Jun; 13(1):9672. PMID: 37316579
We introduce and validate four adaptive models (AMs) to perform a physiologically based Nested-Model-Selection (NMS) estimation of such microvascular parameters as forward volumetric transfer constant, K, plasma volume fraction, v,...
20.
Coventry W, Farraway S, Larsen S, Enis T, Forbes A, Brown S
PLoS One . 2023 Jun; 18(6):e0285739. PMID: 37294805
Recent longitudinal research using the random-intercept cross-lagged panel model (RI-CLPM), which disentangles the within and between variances, has afforded greater insights than previously possible. Moreover, the impact of reading enjoyment...